FindTrial
Sign In

Study on the Mechanism of Dimethyl Fumarate in Alleviating Dry Eye Syndrome by Inhibiting Th17 Cells

Study on the Mechanism of Dimethyl Fumarate in Alleviating Dry Eye Syndrome by Inhibiting Th17 Cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096164
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-01-22
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye disease

Interventions

Dimethyl fumarate group:None
Solvent group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: tear film break-up time =1 point; Healthy controls consisted of individuals without any eye disease.

Exclusion criteria

Exclusion criteria: Any patient who is not considered suitable for inclusion by the investigator

Design outcomes

Primary

MeasureTime frame
The ratio of Th17 cells;—

Countries

China

Contacts

Public ContactRuihua Wei

Tianjin Medical University Eye Hospital

weirhua2009@126.com+86 13920685016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026